Camurus AB: FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease
LUND, Sweden, Sept. 16, 2021 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for the company's
Source: finanznachrichten.de